Alpha Paradigm Partners LLC bought a new stake in Identiv, Inc. (NASDAQ:INVE) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 21,851 shares of the technology company’s stock, valued at approximately $371,000.
A number of other institutional investors have also recently bought and sold shares of INVE. Ameritas Investment Partners Inc. bought a new position in Identiv in the second quarter valued at about $28,000. Legal & General Group Plc bought a new position in Identiv in the second quarter valued at about $36,000. JPMorgan Chase & Co. bought a new position in Identiv in the second quarter valued at about $135,000. Barclays PLC raised its position in Identiv by 180.9% in the first quarter. Barclays PLC now owns 13,097 shares of the technology company’s stock valued at $150,000 after purchasing an additional 8,435 shares during the last quarter. Finally, The Manufacturers Life Insurance Company bought a new position in Identiv in the second quarter valued at about $217,000. Hedge funds and other institutional investors own 58.50% of the company’s stock.
NASDAQ INVE opened at $18.65 on Thursday. The business has a 50 day simple moving average of $18.12 and a 200 day simple moving average of $16.14. Identiv, Inc. has a one year low of $5.91 and a one year high of $21.18. The stock has a market capitalization of $413.28 million, a P/E ratio of -466.25 and a beta of 1.80.
In other Identiv news, CEO Steven Humphreys sold 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 13th. The stock was sold at an average price of $18.25, for a total value of $456,250.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director James E. Ousley sold 5,555 shares of the firm’s stock in a transaction that occurred on Monday, September 20th. The shares were sold at an average price of $18.31, for a total value of $101,712.05. The disclosure for this sale can be found here. Insiders have sold 127,777 shares of company stock valued at $2,385,680 in the last ninety days. 8.60% of the stock is currently owned by insiders.
INVE has been the subject of several research reports. B. Riley increased their target price on Identiv from $22.00 to $26.00 and gave the company a “buy” rating in a research report on Monday, September 20th. Zacks Investment Research downgraded Identiv from a “buy” rating to a “hold” rating in a research report on Friday, August 6th. Finally, Lake Street Capital raised their price objective on Identiv from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Tuesday, September 28th.
Identiv, Inc engages in the provision of physical security and secure identification solutions. Its products include physical access control and video, logical access control, credentials, and RFID inlays and tags. The firm serves the government, healthcare, airports and aviation, and education. It operates through the Identity and Premises segments.
See Also: What is a dead cat bounce?
Want to see what other hedge funds are holding INVE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Identiv, Inc. (NASDAQ:INVE).
Receive News & Ratings for Identiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Identiv and related companies with MarketBeat.com's FREE daily email newsletter.